Speaker

Dr Andy Singleton, Laboratory of Neurogenetics, NIA NIH, Bethesda, USA

Dr Maria Isaac

Dr Singleton received his BSc from the University of Sunderland, UK and his PhD from the University of Newcastle upon Tyne, UK. Dr Singleton’s research initially focused on genetic determinants of dementia, in particular Alzheimer’s disease and dementia with Lewy bodies. His postdoctoral studies were spent at the Mayo Clinic in Jacksonville Florida. Dr Singleton moved to the National Institute on Aging at NIH Bethesda, MD, USA, in 2001 and became a principal investigator leading the molecular genetics unit in 2002. In 2007, Dr Singleton became a tenured senior investigator at the National Institute on Aging and in 2008 became Chief of the Laboratory of Neurogenetics. Dr Singleton has published more than 400 articles on a wide variety of topics. His laboratory works on the genetic basis of neurological disorders with the aim of identifying genetic variability that causes or contributes to disease and using this knowledge to understand the underlying molecular processes.  Dr Singleton currently serves on the scientific advisory board of the Michael J Fox Foundation and the Lewy Body Dementia Association; he is a member of the editorial boards of Neurodegenerative Diseases, Neurogenetics, Movement Disorders, Brain (Associate Editor, Genetics), The Lancet Neurology, the Journal of Parkinson’s Disease, NPJ Parkinson’s Disease, the Journal of Huntington’s Disease, and Annals of Neurology. Dr Singleton was awarded the Boehringer Mannheim Research Award in 2005, the NIH Director’s Award in 2008, and the Annemarie Opprecht Award in 2008. In 2012, Dr Singleton became the first person to win the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research.

« Go Back

Supporting Publication
Organised by
 
  • Lancet Neurology
  • Elsevier
Silver Sponsor
 
Teva
Sponsors
 
AstraZeneca